• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Medical Equipment/Devices
  • Sub-Industry: Life Science Equipment

Myriad Genetics Inc

+ Add to Watchlist

MYGN:US

37.0500 USD 0.9400 2.60%

As of 20:10:00 ET on 07/29/2014.

Snapshot for Myriad Genetics Inc (MYGN)

Open: 36.1000 Day's Range: 36.0800 - 37.4300 Volume: 642,733
Previous Close: 36.1100 52wk Range: 20.0200 - 42.5000 1-Yr Rtn: +23.29%

Stock Chart for MYGN

No chart data available.
  • MYGN:US 37.0800
  • 1D
  • 1M
  • 1Y
36.1100
Interactive MYGN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MYGN

Current P/E Ratio (ttm) 15.5021
Estimated P/E(06/2014) 15.4633
Relative P/E vs. SPX 0.8622
Earnings Per Share (USD) (ttm) 2.3900
Est. EPS (USD) (06/2014) 2.3960
Est. PEG Ratio 0.9783
Market Cap (M USD) 2,772.22
Shares Outstanding (M) 74.82
30 Day Average Volume 773,362
Price/Book (mrq) 3.8224
Price/Sale (ttm) 3.7377
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/13/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MYGN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for MYGN

Myriad Genetics, Inc. develops and markets molecular diagnostic products to provide physicians with information to help guide the care of their patients, to prevent disease, delay the onset of disease, or catch disease at an early stage.

Peter D MeldrumPresident/CEO/Co-FounderJames S Evans "Jim"CFO/Treasurer
Robert Gardner HarrisonChief Information OfficerJerry S LanchburyChief Scientific Officer
More Company Profile & Key Executives for MYGN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil